Clinical Trials Logo

Breast Screening clinical trials

View clinical trials related to Breast Screening.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04761055 Active, not recruiting - Breast Screening Clinical Trials

Study of iBreast, a Handheld Device to Detect Breast Abnormalities During Screening Visits for Breast Cancer

Start date: January 29, 2021
Phase: N/A
Study type: Interventional

This study will test the iBreastExam device to find out whether it can detect a mass or lump in the breast as accurately as a routine breast cancer screening examination. The iBreastExam is a handheld device that performs a painless electronic palpation (examination by touch) of the breast. The device is designed to detect breast abnormalities that may require breast imaging and additional clinical examination by a nurse or doctor. The iBreastExam device creates a color map of the breast, with red spots indicating areas that may be abnormal.

NCT ID: NCT03672331 Active, not recruiting - Breast Screening Clinical Trials

My Personalized Breast Screening

MyPeBS
Start date: July 18, 2019
Phase: N/A
Study type: Interventional

MyPeBS is an international randomized, open-label, multicentric, study assessing the effectiveness of a risk-based breast cancer screening strategy (using clinical risk scores and polymorphisms) compared to standard screening (according to the current national guidelines in each participating country) in detecting stage 2 or higher breast cancers. Women will be differentially screened for 4 years and then, after an end-of-study mammogram, they will return to the routine screening practice. The main study endpoint will be measured at the end of the four years of intervention. Furthermore, follow up data will be collected for 15 years from study entry for evaluation of long-term cumulative breast cancer incidence and breast cancer-specific survival